Caribou Biosciences Inc

NAS:CRBU (USA)   Ordinary Shares
$ 3.11 +0.02 (+0.65%) 10:09 PM EST
At Loss
P/B:
0.82
Market Cap:
$ 280.89M
Enterprise V:
$ 12.25M
Volume:
2.67M
Avg Vol (2M):
1.84M
Volume:
2.67M
At Loss
Avg Vol (2M):
1.84M

Business Description

Caribou Biosciences Inc
NAICS : 541713 SIC : 2833
ISIN : US1420381089

Share Class Description:

CRBU: Ordinary Shares
Description
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
Name Current Vs Industry Vs History
Cash-To-Debt 10.83
Equity-to-Asset 0.84
Debt-to-Equity 0.08
Debt-to-EBITDA -0.21
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.46
Distress
Grey
Safe
Beneish M-Score -2.32
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 18.55
9-Day RSI 24.54
14-Day RSI 27.21
6-1 Month Momentum % -29.88
12-1 Month Momentum % -16.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.49
Quick Ratio 10.49
Cash Ratio 10.13
Days Sales Outstanding 9.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -47.3
Shareholder Yield % -57.45

Financials (Next Earnings Date:2024-08-08 Est.)

CRBU's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CRBU

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Caribou Biosciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 33.404
EPS (TTM) ($) -1.46
Beta 0
Volatility % 117.89
14-Day RSI 27.21
14-Day ATR ($) 0.257148
20-Day SMA ($) 3.5765
12-1 Month Momentum % -16.53
52-Week Range ($) 2.98 - 8.5899
Shares Outstanding (Mil) 90.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Caribou Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Caribou Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Caribou Biosciences Inc Frequently Asked Questions

What is Caribou Biosciences Inc(CRBU)'s stock price today?
The current price of CRBU is $3.11. The 52 week high of CRBU is $8.59 and 52 week low is $2.98.
When is next earnings date of Caribou Biosciences Inc(CRBU)?
The next earnings date of Caribou Biosciences Inc(CRBU) is 2024-08-08 Est..
Does Caribou Biosciences Inc(CRBU) pay dividends? If so, how much?
Caribou Biosciences Inc(CRBU) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1